期刊文献+

中心静脉压在评估老年维持性血液透析患者超滤量的意义

Roles of central venous pressure on evaluating ultrafiltration volume in old patients receiving maintenance hemodialysis
下载PDF
导出
摘要 目的研究中心静脉压(CVP)在调节超滤量中的作用。方法对44例老年维持性血液透析患者进行对照研究,22例对照组根据体重增量估算超滤量,另22例观察组在此基础上,根据CVP的变化来调节超滤量,对两组低血压、肌肉抽搐、心力衰竭发生率,以及6个月前后SBP、DBP、心胸比例(CTR)、下腔静脉直径/体表面积(VCD)进行比较。结果观察组患者低血压、肌肉抽搐及心力衰竭发生率分别为11.41%、9.39%、2.14%,低于对照组的26.16%、14.29%、3.75%,差异均有统计学意义(χ2分别=112.75、18.12、7.10,P均<0.05)。6个月前后比较,观察组除DBP外,6个月后SBP、CTR及VCD分别为(131.30±12.09)mmHg、(0.53±0.05)及(11.89±3.29)mm/m2,均低于6个月前的(164.45±29.39)mmHg、(0.58±0.08)及(14.10±3.78)mm/m2,差异均有统计学意义(t分别=4.89、2.50、2.07,P均<0.05),对照组6个月前后SBP、DBP、CTR及VCD比较,差异均无统计学意义(t分别=0.08、0.43、0.48,P均>0.05)。结论以CVP结合体重增量调节老年MHD患者超滤量,可降低透析过程中低血压、肌肉抽搐发生率,并能改善患者SBP、CTR、VCD等容量相关指标。 Objective To explore the roles of central venous pressure on adjusting uhrafiltration volume in old patients receiving maintenance hemodialysis. Methods Forty-four old patients receiving maintenance hemodialysis were investigated. Uhrafihration volume was estimated by weight increment in half of them (control group), and by weight increment combined with CVP in the other (observation group). Then, the incidence of hypotension, spasm, heart failure, and systolic blood pressure (SBP), diastolic blood pressure (DBP), cardiothoracic ratio (CTR), inferior vena cava diameter-body surface area ratio (VCD) were detected within six months. Results The incidences of hypotension, spasm and heart failure were significantly lower in the observation group than those in the control group, 11.41%,9.39%,2.14%,vs 26.16%,14.29%,3.75%(x2=112.75,18.12,7.10,P〈0.05). The levels of SBP,CTR,VCD were markedly decreased in the observational group six months later , from (164.45±29.39) mmHg, (0.58±0.08), (14.10± 3.78) mm/m2 to (131.30±12.09) mmHg, (0.53±0.05),(11.89±3.29) mm/m2 (t=-4.89,2.50,2.07,P〈0.05). Conclusions It could decrease the incidences of hypotension, spasm and heart failure that adjusts uhrafihration volume by means of weight increment combined CVP, and improve the indiees such as SBP, CTR and VCD in old patients receiving maintenance hemodialysis.
出处 《全科医学临床与教育》 2010年第2期156-158,共3页 Clinical Education of General Practice
关键词 维持性血液透析 超滤量 体重增量 中心静脉压 maintenance hemodialysis uhrafihration volume weight increment central venous pressure
  • 相关文献

参考文献7

  • 1Foley RN,Herzog CA,Collins AJ.Blood pressure and long term mortality in United States hemodialysis patients.USRDS Waves 3 and 4 Study[J].Kidney Int,2002,62(8):1784-1790.
  • 2Davenport A.Intradialytic complications during haemodialysis[J].Hemodial Int,2006,10(2):162-167.
  • 3Kamyar KZ,Ryan D,Kilpatrick,et al.Reverse Epidemiology of Hypertension and Cardiovascular Death in the Hemodialysis Population[J].Hypertension,2005,45(2):811-817.
  • 4周福德,蔡红梅,王梅.血液透析患者血容量监测的意义[J].肾脏病与透析肾移植杂志,2001,10(6):528-531. 被引量:42
  • 5Foley RN,Herzog CA,Collins AJ.Blood pressure and longterm mortality in United States haemodialysis patients:USRDS Waves 3 and 4 stuay[J].Kidney Int,2002,62(5):1784-1790.
  • 6Fagugli RM,Pasini P,Quintaliani G,et al.Association between extracellular water,left ventricular mass and hypertension in haemodialysis patients[J].Nephrol Dial Transplant,2003,18(11):2332-2338.
  • 7刘惠兰,周亦伦,段晓峰.ANP、cGMP和ICVD对血液透析患者干体重评价的意义[J].中国血液净化,2003,2(12):648-650. 被引量:21

二级参考文献11

  • 1[1]Cheriex EC, Leunissen KML, Jansen JHA, et al.Echography of the inferior vena cava is a simple and reliable tool for estimation of 'dry weight' in haemodialysis patients. Nephrol Dial Transplant, 1989,4: 563-568
  • 2[2]Haug C, Metzele A, Steffgen J, et al. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure. Clin Investig, 1994,72:430-434
  • 3[3]Takahashi M, Nagake Y, Ichikawa H, et al. Plasma concentrations of natriuretic peptides in patients on hemodialysis. Research communications in molecular pathology and pharmacology,1996,92(1)
  • 4[4]Fishbane S, Natke E, Maesaka J.Role of volume overload in dialysis-refractory hypertension. Am J Kidney Dis, 1996,28:257-261
  • 5[5]Lauster F, Heim JM, Drummer C, et al. Plasma cGMP level as a marker of the hydration state in renal replacement therapy. Kidney Int Suppl,1993,41:S57-9
  • 6[6]Franz M, Pohanka E, Tribl B, et al. Living on chronic hemodialysis between dryness and fluid overload. Kidney Int Suppl,1997,59:S39-42
  • 7[7]Osajima A, Okazaki M, Kato H,et al. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease. Am J Nephrol, 2001,21(2):112-9
  • 8[8]Tetsuka T, Ando Y, Ono S, et al. Change in inferior vena caval diameter detected by ultrasonography during and after hemodialysis. ASAIO J, 1995,41(1):105-10
  • 9[9]Katzarski K.S, Randmaa, Bergstrom: Influence of hemodialysis on intravascular volume and vasoactive hormones. Clinical Nephrology ,1999,52: 304-311
  • 10[10]Leunissen KM. Fluid status in haemodialysed patients. Nephrol Dial Transplant,1995,10(2):153-5

共引文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部